Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Marker Therapeutics MRKR stock worth buying today Q4 2025 EPS Exceeds Expectations CISS C3is Inc posts 472 percent year over year Q3 2025 revenue growth shares climb 268 percent The capital expenditure plan at Allied Gaming AGAE Newmont NEM Stock Is It a Good Entry Point Slight Loss 20260420 EVI Industries EVI posts 72 Q1 2026 EPS miss with shares dipping 025 in todays trading Metagenomi Therapeutics MGX Stock Sentiment Analysis Weakens 20260422 Duke Energy DUK Foundation Launches First Round of America250 Green Stewardship Grants in South Carolina Reinforcing ESG and Community Engagement Targets Green Card for the Planet FIFAs 2026 World Cup Faces Mounting Climate and Financial Risks Europes BestPerforming Stocks of 2026 Swedish Photonics Leads with a 947 Surge REITs Lead the Charge in OffMarket Senior Living MA Deals Lifezone LZM Fell 429 Is a Recovery Ahead 20260518 Mercury Systems MRCY Down 266 How Low Could It Go 20260517 Rising RDACR Declines 2154 Amid Market Weakness 20260517 Reliance Industries Sets June 19 for 49th AGM Announces FY26 Dividend Record Date Why Bonds May Not Provide the Expected Safety Net in the Next Market Shock UK Energy Vulnerability May Require Deeper State Intervention Amid Cost of Living Measures Japan and Philippines Strengthen Strategic Ties Amid Regional Security Concerns Astera Labs Shares Surge 32 Following Bullish Analyst Coverage Ondas Holdings Pursues DefenseAI Strategy with Autonomous Systems Focus CLNN Q1 2026 Earnings EPS Surges Past Estimates but Stock Falls on Absence of Revenue HTCR Q2 2025 Earnings Massive Earnings Surprise Drives DoubleDigit Stock Rally SBET Earnings Overview 20260528 PAYO Q1 2026 Earnings EPS Surpasses Estimates by 3245 as Core Growth Momentum Continues urbangro Inc UGRO Q3 2025 Earnings Staggering Loss Shocks Market Amid Missing Revenue Data WW Grainger GWW Edges Higher Testing Key Resistance Zone Rekor Systems REKR Holds at 077 as Minor Decline Tests Support Levels Acrivon Therapeutics ACRV Narrows Lower as Biotech Sentiment Remains Cautious Toronto Dominion Bank TD Edges Higher as Investors Assess Support Levels Affiliated Managers Group AMG Holds Steady Near Resistance as Volume Remains Moderate Cronos Group CRON Flat as Stock Hovers Near Support Awaiting Catalyst Home Affordability Crisis Deepens One Propertys Journey Reflects Soaring Costs SpaceX IPO Potential Pathways for Retail Investors to Participate